Montag & Caldwell Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$230M |
| 2 |
Booking.com
BKNG
|
+$228M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$124M |
| 4 |
Franklin Resources
BEN
|
+$103M |
| 5 |
Teradata
TDC
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$264M |
| 2 |
MON
Monsanto Co
MON
|
+$138M |
| 3 |
Oracle
ORCL
|
+$138M |
| 4 |
Sanofi
SNY
|
+$127M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.33% |
| 2 | Healthcare | 19.26% |
| 3 | Consumer Discretionary | 15.77% |
| 4 | Financials | 10.3% |
| 5 | Technology | 9.57% |
Similar funds
Montag & Caldwell's Q3 2013 Portfolio in Review
As of Q3 2013, Montag & Caldwell held 104 positions worth $13.3B, down 0.42% from $13.3B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Montag & Caldwell withdrew a net $651M in Q3 2013, closing 7 positions and reducing 33 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Montag & Caldwell opened a new position in Gilead Sciences worth $242M.
- Montag & Caldwell's largest Q3 2013 buy was Gilead Sciences: 3,844,332 shares worth $242M.
- Montag & Caldwell added most to Alphabet (Google) Class C in Q3 2013, an estimated $124M increase.
- Montag & Caldwell's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $138M.
- Montag & Caldwell fully exited Unilever NV New York Registry Shares in Q3 2013, selling an estimated $264M.
- Montag & Caldwell's ten largest holdings make up 35% of its $13.3B portfolio in Q3 2013.
- Montag & Caldwell opened 7 new positions and closed 7 in Q3 2013.
- Montag & Caldwell's portfolio value fell 0.42% quarter-over-quarter to $13.3B.
Based on Montag & Caldwell's 13F filing for Q3 2013, filed 13 Nov 2013.